Efficacy and Feasibility of Sorafenib as a Maintenance Agent After Allogeneic Hematopoietic Stem Cell Transplantation for Fms-like Tyrosine Kinase 3 Mutated Acute Myeloid Leukemia: An Update
- Resource Type
- Article
- Source
- In
Clinical Lymphoma, Myeloma and Leukemia August 2019 19(8):506-508 - Subject
- Language
- ISSN
- 2152-2650